Production (Stage)
Metagenomi, Inc.
MGX
$1.73
$0.074.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -57.07% | -16.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -57.07% | -16.50% | |||
| Cost of Revenue | 8.54% | -11.78% | |||
| Gross Profit | -55.09% | 8.09% | |||
| SG&A Expenses | -3.79% | -7.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.66% | -10.80% | |||
| Operating Income | -34.90% | 7.86% | |||
| Income Before Tax | -1.36% | -17.85% | |||
| Income Tax Expenses | 108.11% | 42.64% | |||
| Earnings from Continuing Operations | -7.01% | -24.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.01% | -24.64% | |||
| EBIT | -34.90% | 7.86% | |||
| EBITDA | -38.10% | 8.83% | |||
| EPS Basic | -7.84% | -22.84% | |||
| Normalized Basic EPS | -43.82% | 8.50% | |||
| EPS Diluted | -7.84% | -22.84% | |||
| Normalized Diluted EPS | -43.82% | 8.50% | |||
| Average Basic Shares Outstanding | -0.77% | 1.47% | |||
| Average Diluted Shares Outstanding | -0.77% | 1.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||